Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 793 studies with search of: | "Myelodysplasia" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Terminated |
Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)
|
||||
2 | Recruiting |
A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia
|
||||
3 | Recruiting |
Lenalidomide and Recombinant Human Stem Cell Factor for Treatment of Myelodysplasia
|
||||
4 | Completed |
Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia
|
||||
5 | Recruiting |
A Study of Decitabine, Low Dose Cytarabine and G-CSF in High-Risk Myelodysplastic Syndromes, Refractory Acute Myeloid Leukemia or Acute Myeloid Leukemia in Patients With Significant Co-Morbidities
|
||||
6 | Terminated |
Study of Velcade and Thalidomide in Patients With Myelodysplasia
|
||||
7 | Completed |
VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia
|
||||
8 | Recruiting |
Haploidentical Transplantation in Patients With Acute Leukemia and Myelodysplasia
|
||||
9 | Active, not recruiting |
Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
|
||||
10 | Active, not recruiting |
Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
|
||||
11 | Recruiting |
Vorinostat and Low Dose Cytarabine for High Risk Myelodysplasia
|
||||
12 | Active, not recruiting |
Decitabine in Treating Patients With Myelodysplastic Syndrome
|
||||
13 | Active, not recruiting |
Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes
|
||||
14 | Completed |
Tipifarnib in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome in Complete Remission
|
||||
15 | Completed |
Cholecalciferol in Treating Patients With Myelodysplastic Syndrome
|
||||
16 | Recruiting |
Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
|
||||
17 | Active, not recruiting |
Amifostine in Treating Patients With Myelodysplastic Syndrome
|
||||
18 | Active, not recruiting |
Paricalcitol in Treating Patients With Myelodysplastic Syndrome
|
||||
19 | Active, not recruiting |
Biological Therapy in Treating Patients With Myelodysplastic Syndrome
|
||||
20 | Active, not recruiting |
Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes
|
Previous Page | Studies Shown (1-20) | Next (21-40) |